Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.6800
+0.2001 (41.70%)
At close: Jan 9, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $163.19 million as of January 9, 2026. Its market cap has increased by 19.32% in one year.
Market Cap
163.19M
Enterprise Value
153.35M
Revenue
148.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.68
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 163.19M, an increase of 170.40%. That is a compound annual growth rate of 13.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 163.19M | 96.30% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 506.04M |
| Northwest Biotherapeutics | 405.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 352.88M |
| Silence Therapeutics | 273.96M |